Evidence map›Paper›PMID 35487972›Full record

ArticleScientific reports2022

Increased NUSAP1 expression is associated with lymph node metastasis and survival prognosis in bladder urothelial carcinoma.

Jian Hou, Zhenquan Lu, Xianhua Liu, Bingfeng Luo, Genyi Qu, Yong Xu, Cheng Tang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. The role and therapeutic value of NUSAP1 in human cancers.Journal of translational medicine · 2025
    Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jian Hou *Division of Urology, Department of Surgery, The University of Hongkong-Shenzhen Hospital, Shenzhen, 518000, China.
Zhenquan Lu *Division of Urology, Department of Surgery, The University of Hongkong-Shenzhen Hospital, Shenzhen, 518000, China.
Xianhua Liu *Department of Pathology, Maternity and Child Care Centers in Fujian Province, Fuzhou, 350000, China.
Bingfeng LuoDivision of Urology, Department of Surgery, The University of Hongkong-Shenzhen Hospital, Shenzhen, 518000, China.
Genyi QuDepartment of Urology, Zhuzhou Central Hospital, Zhuzhou, 412007, China. qugenyi@fjmu.edu.cn.
Yong XuDepartment of Urology, Zhuzhou Central Hospital, Zhuzhou, 412007, China. tigerhnllxu@126.com.
Cheng TangDepartment of Urology, Zhuzhou Central Hospital, Zhuzhou, 412007, China.
University of Hong Kong - Shenzhen Hospital · CNZhuzhou Central Hospital · CNFuzhou Maternity and Child Health Care Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The main route of metastasis of bladder urothelial carcinoma is through lymph nodes; however, its exact mechanism remains unclear. In this study, we found an association of nucleolar and spindle associated protein 1 (NUSAP1) expression with BUC tissues along with lymph node metastasis and the survival prognosis. A total of 178 pathological specimens following radical bladder cancer resection were obtained. NUSAP1 expression was analyzed by immunohistochemistry. We evaluated the correlation between clinicopathological characteristics and NUSAP1 expression. Logistic regression was used to determine the independent variables that influenced lymph node metastasis. Uni- and multi-factorial Cox regression methods were used to determine the prognostic value of NUSAP1 expression in urothelial carcinoma of the bladder. High expression of NUSAP1 in BUC was not significantly related to the patient's gender, age, or tumor number (p > 0.05), however was significantly associated with pathological grade, tumor diameter, pathological stage, and lymph node metastasis (p < 0.05). Lymph node metastasis was significantly correlated with pathological stage, pathological grade, tumor number, tumor diameter, and NUSAP1 expression (p < 0.05); only NUSAP1 expression was an independent predictor of lymph node metastasis in BUC (OR:1.786, 95% CI 1.229-2.596, p = 0.002). In addition, high NUSAP1 expression was an independent prognostic predictor for BUC. In BUC, NUSAP1 showed high expression and was significantly associated with lymph node metastasis, pathological stage, pathological grade, and tumor diameter. NUSAP1 was an independent predictor of lymph node metastasis and prognosis in BUC; higher expression indicated poorer prognosis of BUC patients.

Indexed as

Carcinoma, Transitional CellUrinary Bladder NeoplasmsFemaleHumansLymphatic MetastasisMaleMicrotubule-Associated ProteinsPrognosisUrinary BladderMicrotubule-Associated ProteinsNUSAP1 protein, human

Identifiers

PMID35487972
PMCPMC9054847
OpenAlexW4225123174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.